Evidence map›Paper›PMID 42473019›Full record

ArticleAdvanced healthcare materials2026

Hierarchically Engineered Magnetic-Enzymatic Microrobots with Stimuli-Induced Disassembly for Controlled Navigation and Mucosal Penetration in 3D Lung Fibrosis Models.

Zhuluni Fang, Xirui Zeng, Yuxiang Mei, Immihan Ceren Yasa

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhuluni FangThrust of Bioscience and Biomedical Engineering, Systems Hub, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, P. R. China.
Xirui ZengThrusts of Robotics and Autonomous Systems, Systems Hub, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, P. R. China.
Yuxiang MeiThrusts of Robotics and Autonomous Systems, Systems Hub, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, P. R. China.
Immihan Ceren YasaThrust of Bioscience and Biomedical Engineering, Systems Hub, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, P. R. China.ORCID https://orcid.org/0000-0002-5013-7246

Funding

Guangzhou-HKUST(GZ) Joint Funding Program 2025A03J3800National Natural Science Foundation of China W2433114
6 · The paper itself

Abstract

Micro/nanorobots offer a promising approach for active therapeutic delivery to hard-to-access regions of the body. For pulmonary fibrosis, however, targeted drug delivery remains difficult because the disease has spatially heterogeneous fibrotic lesions and mucus accumulation. Importantly, achieving lesion targeting and mucus penetration remains challenging due to the trade-off between long-distance navigation and the ability to traverse dense biological barriers. Here, we present a hierarchically structured microrobot that integrates magnetically driven microrollers with self-propelled enzymatic nanomotors for sequential drug delivery via a thioketal linker responsive to reactive oxygen species (ROS). The hierarchical microrobots exhibit programmable navigation on inclined, mucus-coated surfaces under airflow and undergo disassembly in oxidative fibrotic environments. Following deployment, the released enzymatic nanomotors actively penetrate mucus barriers and deliver anti-fibrotic drugs. In a three-dimensional (3D) in vitro fibrosis model incorporating a mucus-epithelial barrier, drug-loaded enzymatic nanomotors achieve superior penetration and significantly greater anti-fibrotic efficacy than passive nanoparticles. Overall, this work establishes a hierarchical microrobotic platform that enables both targeted transport and active mucus penetration for localized therapeutic delivery in complex biological environments and provides a general strategy for integrating targeting and tissue penetration within a single platform.

Indexed as

Drug Delivery SystemsPulmonary FibrosisRoboticsAnimalsHumansReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

PMID42473019
PMCPMC13474131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.